The pancreatic stone protein and its secretory form (PSP-S) are inhibitors of CaCO3 crystal growth, possibly involved in the stabilization of pancreatic juice. We have established the structure of PSP-S mRNA and monitored its expression in chronic calcifying pancreatitis (CCP). A cDNA encoding pre-PSP-S has been cloned from a human pancreatic cDNA library. Its nucleotide sequence revealed that it comprised all but the 5' end of PSP-S mRNA, which was obtained by sequencing the first exon of the PSP-S gene. The complete mRNA sequence is 775 nucleotides long, including 5'-and 3'-noncoding regions of 80 and 197 nucleotides, respectively, attached to a poly(A) tail of -125 nucleotides. It encodes a preprotein of 166 amino acids, including a prepeptide of 22 amino acids. No overall sequence homology was found between PSP-S and other pancreatic proteins. Some homology with several serine proteases was observed in the COOH-terminal region, however. The mRNA levels of PSP-S, trypsinogen, chymotrypsinogen, and colipase in CCP and control pancreas were compared. PSP-S mRNA was three times lower in CCP than in control, whereas the others were not altered. It was concluded that PSP-S gene expression is specifically reduced in CCP patients.
Introduction
Pancreatic secretion of vertebrates contains -20 major protein components (1) . The structure and function of most of them have been the subject of numerous studies in the last decades. Secretory protein includes zymogens, enzymes, an enzyme cofactor (colipase) and a trypsin inhibitor, all ofwhich are directly involved in the digestive process. More recently, our laboratory reported the presence in human pancreas of a polymorphic glycoprotein without recognized enzyme activity (2) . It was named "secretory pancreatic stone protein" (PSP-S)l because of its immunological identity with the "pancreatic 1. Abbreviations used in this paper: CCP, chronic calcifying pancreatitis; PSP, pancreatic stone protein; PSP-S, secretory forms of the pancreatic stone protein; PTP, pancreatic thread protein.
stone protein," the major component of the protein matrix present in calculi of patients suffering from chronic calcifying pancreatitis (CCP) (3) . In human pancreatic juice collected over an appropriate mixture of protease inhibitors, PSP-S comprised four species with Mr between 16 and 20 kD, named PSP-S2 to PSP-S5 (4) . Immunoprecipitation of in vitro translation products of pancreatic RNAs showed that PSP-S was synthesized as a single polypeptide (5) . Hence, its molecular weight heterogeneity is probably due to posttranslational processing. An additional PSP-S form (PSP-Sl) with a Mr of 15 kD appears in juice upon activation (controlled or not), albeit minimal. PSP-Sl derives from PSP-S2-5 by trypsin-like cleavage of an Arg-Ile bond in the NH2-terminal part of the PSP-S backbone (6) . PSP-Sl was independently discovered by Gross et al. in human (7) and bovine (8) secretions, and named "'pancreatic thread protein" (PTP) because of its ability to form fibrils at neutral pH.
The abundance of PSP-S in juice (10-14% oftotal protein) suggests that it plays an important role in the exocrine pancreatic function. In vitro experiments have shown that PSP-S inhibited CaCO3 crystal growth (9) . Evidence that normal pancreatic secretion is supersaturated in CaCO3 (10) 'prompted us to suggest that the physiological role of PSP-S may be related to its inhibitory properties. The demonstration that PSP-S concentration was diminished in the juice ofpatients suffering from chronic calcifying pancreatitis supported that hypothesis (11). In this work, we report the cloning and complete sequencing of human PSP-S mRNA, and the alterations of its expression associated with CCP.
Methods

Experimental procedures
Construction ofa human pancreatic cDNA library in XgtJO. Total RNA was prepared from fragments of human pancreas by the technique of Chirgwin et al. (12) . The polyadenylated fraction was purified by affinity chromatography on oligo-dT cellulose (13) , and used to direct cDNA synthesis in the presence of reverse transcriptase. DNA polymerase was used in conjunction with RNase H to synthesize the complementary cDNA strands. Enzymes and reagents were obtained as a kit from Amersham International (Amersham, UK) and used according to their recommendations. The double-strand (ds)-cDNA was ligated into bacteriophage XgtlO DNA with Eco RI linkers and packaged using the Amersham packaging kit. The library contained a total of 5.5 X 104 independent recombinant clones, and was amplified to a titer of 3 X 1010 plaque-forming units (pfu)/ml.
Biohazards associated with the experiments described in this publication have been examined previously by the French National Control Committee.
Library screening. The cDNA library was screened by the "plaque screening" procedure (14) , with a 23-mer oligonucleotide mixture cov-ering all possible sequences encoding the octapeptide DLYCQNMN present in position 61-68 of pre-PSP-S ("BL-I," kindly synthesized by Dr. J. L. Berge-Lefranc, INSERM U38, Marseille). The oligonucleotides were labeled with [a-32P]ATP and T4 polynucleotide kinase (15) to a specific activity of 1-2 X 109 cpm/fig, and used to screen in duplicate -105 pfu. 15 positive clones were amplified and screened again in the same conditions except that they were plated at a much lower density; 25 individual positive plaques were obtained. Screening conditions were the following (16, 17) : the filters were prehybridized for 2 h at 370C in 6X SSC,1X Denhardt's solution, 0.5% SDS, 0.05% Na pyrophosphate, and 100 ;tg/ml salmon sperm DNA. Hybridization was conducted at 370C for 16 h in the same buffer in which salmon sperm DNA was replaced by 20 ug/ml tRNA, in the presence of 0.5-1 X I09 cpm of oligonucleotide probe. Filters were then washed twice for h and several times at 370C, 15 min each in 6X SSC, 0.05% Na pyrophosphate, until <100 cps could be detected with a portable Geiger counter (Mini Instruments Ltd, Burnham-on-Crouch, UK).
A human genomic library in the bacteriophage XEMBL3 was purchased from Clontech Laboratories (Palo Alto, CA). It was screened for potential PSP-S genomic clones with a PSP-S cDNA fragment (i3 1) and 32P-labeled by random priming (18) to a specific activity of 109 cpm/;g. A first plaque screening was performed in duplicate on 105 pfu, and the positivity of the clones was confirmed by rescreening individual plaques, which were eventually purified (14) . Hybridization and washing conditions were as described by Southern (19) . DNA and RNA analysis by filter hybridization. DNA fragments were transferred to nitrocellulose filters either from 0.4% agarose gels by the technique of Southern (19) , or from 7% acrylamide gels by electrotransfer (20) . Hybridization conditions with oligonucleotides or inserts were the same as for plaque screening. RNAs were analyzed by electrophoresis on agarose-methylmercury gels (21), transferred to nitrocellulose, and hybridized to random primer-labeled inserts by the technique of Thomas (22) . Quantitative dot-blot analysis of RNAs was performed according to White and Bancroft (23) as already described (24) . Human chymotrypsinogen, trypsinogen, and colipase cDNA probes were selected from the cDNA library by oligonucleotide screening or heterologous hybridization using the corresponding rat probes (kindly provided by Dr. R. MacDonald, University of Texas, Dallas TX) and their nature confirmed by sequencing. The autoradiographs were scanned with a Multiscan apparatus (LKB Instruments, Gaithersburg, MD), and the results analyzed as in reference 24.
Primer extension experiments. S ;Lg of pancreatic RNA were incubated in 5 mM methyl mercury hydroxide for 10 min at room temperature and then used in the cDNA synthesis procedure described by Maniatis et al. (25) , in which oligo-dT was replaced by 100 ng of the oligonucleotide DG3, 32P-labeled by kinasing to 2 X 109 cpm/ug. DNA sequencing. DNA fragments were subcloned in the M13 mpl8/mpl9 system (26), and the single stranded recombinant phages were sequenced with Sequenase (United States Biochemical Corp., Cleveland, OH) by the method of Sanger (27) , following the protocol supplied. Sequencing was initiated either by the universal M13 primer or by appropriate synthetic oligonucleotides as described in figure legends.
Sequence comparison. The complete nucleotide sequence of PSP-S mRNA was compared with the 15,465 sequences of Genbank (28) . The search was conducted with the BISANCE system (CITI2, Centre Interuniversitaire d'Informatique, Paris) using the program of Kanehisa (29) . The complete amino acid sequence was compared with the 5,415 sequences ofthe National Biomedical Research Foundation data bank, using the FASTP program (CITIZ) (30) .
Patients
Four fragments of pancreas were obtained from cadaver kidney transplant donors (three males, one female, aged 14-40 yr). The pancreases were macroscopically normal but no histological study was performed.
The other fragments were obtained from the Service de Gastroenterologie, HOpital Sainte-Marguerite, Marseille. Three samples were taken at surgery from patients presenting with obstructive pancreatitis due to endocrine tumors. The diagnoses have been verified on histological sections of the resected pancreas that confirmed the tumors and showed the typical lesions of obstructive pancreatitis and the absence of calcifications. These patients were two males and a female whose ages ranged from 62 to 67. Their average daily alcohol consumption was 0, 50, and 110 ml ethanol per d. The four donors and the three cases of obstructive pancreatitis served as controls. In five patients, the diagnosis of chronic pancreatitis was done on histological sections of the resected pancreas. Four of the patients presented with visible pancreatic calculi (calcifications) on x-ray films of the abdomen. The fifth case was a man who used to drink 200 ml ethanol per d for years, when he started presenting 7 yr ago with recurrent attacks of pancreatic pain. Surgery was indicated because on retrograde pancreatography, the only anomaly was a dilation of a collateral duct in the head of the pancreas. As a small cancer could not be excluded in a patient presenting with neither visible pancreatic calculi nor exocrine or endocrine insufficiency, a cephalic duodenopancreatectomy was performed. The first routine sections only showed a slight degree of periductal fibrosis and no tumor. Systematic histological examination of the pancreatic head was then performed, which revealed typical lesions of chronic pancreatitis in a few groups of lobules. A decreased number of acini, dilation of small ducts with atrophy of their epithelium, and large intraductal plugs were found. We diagnosed a very slight but typical form of CCP. These five patients were males aged 45-54. Their daily alcohol consumption was 30, 60, 200, 300, and 600 ml ethanol per d.
Results
Screening the XgtlO library of human pancreatic cDNA for PSP-S clones. A stretch of seven amino acids with minimum codon degeneracy was chosen in the PSP sequence, and a mixture of 128 23-mer oligonucleotides covering all possible sequences homologous to the corresponding mRNA was synthesized (BL-1, Fig. 1 Fig. 2 A) . Hence, at least 31 nucleotides were missing from the 5' ofthe cDNA inserted into DG3-2. A "strong stop" (premature termination of the extension) was observed 10 nucleotides downstream. Sequence ofa PSP-S genefragment including the 5' end of the RNA (Fig. 3) (Fig. 3) . The mRNA start site predicted from the primer extension experiment (Fig. 2 A) was a thymidine, 82 nucleotides upstream from the first possible initiation codon. Finding a pyrimidine in position 1 is not usual, but sequences around and upstream from that nucleotide conform to the consensus established for protein-coding genes (31, 32): a typical promoter sequence (TAGAAA) was present at position -27, and pyrimidines were found in positions -1 and 2-6. No other position in the region compatible with our data met any of the requirements for a mRNA start site.
The coding sequence that started at position 82 was interrupted at position 146. A very strong homology was observed when the sequence around nucleotide 146 was compared with the consensus exon-intron boundary sequence (33) . The 235-bp gene fragment therefore contains the 3' end of the PSP-S gene first exon followed by 42 nucleotides of intronic sequence.
Analysis ofPSP-S mRNA sequence. The sequence ofPSP-S mRNA, obtained by alignment of the cDNA clones DG3-2-282 and DG3-2-5 10 ( Fig. 1) , and completed by data from the genomic clone XHG-2 comprises 775 nucleotides, excluding the poly(A) tail (Fig. 4) . The size of that mRNA, estimated by Northern blot analysis of total pancreatic RNA, is -900 nucleotides (Fig. 2 B) . A poly(A) tail of -125 nucleotides is therefore attached to mature PSP-S mRNA, only a portion of which was present in the cDNA.
Three methionines at positions 81, 105, and 123 are potential initiation sites for translation. In vertebrates, however, protein synthesis typically starts from the upstream methionine (34) . The Eco RI linker bordering the 5' end of XDG3-2 insert is indicated. In lanes S-8 were loaded, respectively, 0.3, 0.7, 1.5, and 3 X 103 cpm of the primer extension reaction. Two major bands were visible, corresponding to cDNAs, respectively, 21 and 31 nucleotides longer than the cDNA inserted in XDG3-2.
(B) Northern blot: 5 1Ag of pancreatic RNA were submitted to agarose-methylmercury gel electrophoresis and transferred onto nitrocellulose. The inserts of clones DG3-2-294 and DG3-2-5 10, respectively, homologous to the 5' and 3' ends of PSP-S mRNA were 32P-labeled and hybridized either independently or in combination to the transferred RNA. In the three instances, a single band was revealed, whose length was estimated to 900 nucleotides (arrow) by comparison with markers run in parallel. Its sequence conforms to the characteristics of eukaryotic signal sequences, with an NH2-terminal net charge of +1 and a hydrophobic core (37) . Interestingly enough, the 3' boundary of the first exon in the PSP-S gene (Fig. 3) corresponds to the end ofthe prepeptide (Gly in position 22) , showing segregation in that exon ofa functional domain ofthe protein, as described for other secretory proteins (31, 38). Mature PSP-S is a 1-44-amino acids polypeptide (Fig. 4) . The Arg-lle bond cleaved by trypsin in PSP-S to generate PSP-Sl was found 11 residues downstream from the initial glutamine, and the following 133-amino acid sequence was identical to the PSP-S1 sequence already published. The predicted COOH-terminal end coincided with the end of PSP-S1, excluding posttranslational processing in that region.
Comparison of the COOH-terminal sequences of PSP-S and other serine proteases. A first computer search for homologies between the nucleotide sequence of PSP-S mRNA and the 15,465 sequences indexed in Genbank gave negative reaq44q44aqat qt t aoa4aat aaca~qt ict C qc tc tC ttcttcaaaccCtcctCttcCctqitttctcCtacaqagqttqCt4otttqctcCttaaqcaaqagat tcaCtQcoC4taauc ATG GCT CAG ACC AAC TCG TTC (Fig. 1) and from the PSP-S genomic clone (Fig. 3) sults. A second search was conducted in the National Biomedical Research Foundation protein bank of 5,415 sequences. As shown on Fig. 5 , significant homology was observed in the COOH-terminal regions of PSP-S and several serine proteases: bovine and human trypsinogens, bovine chymotrypsinogen, and plasmatic kallikrein. It is noteworthy that the tripeptide Ser-Trp-Gly, which is involved in the specificity pocket ofpancreatic serine proteases (39) , is present at positions 123-125 of PSP-S.
Expression ofPSP-S, trypsinogen, chymotrypsinogen, and colipase mRNAs in thepancreas ofcontrols andpatients suffering from CCP. Quantitative filter hybridization experiments (dot blots) were conducted on total RNA extracted from pancreatic fragments obtained from five patients presenting with CCP and from seven control individuals (Fig. 6 ). PSP-S mRNA concentration was significantly lower in CCP than in control, with a mean value of 388±70 OD492 U/,ug RNA compared 1,167±187 OD492 U/hg RNA in controls. In the latter group, no significant difference was observed between fiagments from pancreatic surgery and from kidney transplantation donors. In contrast to PSP-S, no significant difference was observed between controls and CCP patients in the concentrations of trypsinogen, chymotrypsinogen, and colipase mRNAs. Mean values (±SE) for CCP and controls were, respectively:trypsinogen, 590±157 and 637±94; chymotrypsinogen, 430±78 and 368±36; and colipase, 417±137 and 533±136.
Records of daily alcohol consumption were not available in transplantation donors. In the other cases (three controls, five CCP), values obtained were in the same range for both groups and did not correlate with PSP-S mRNA concentrations (not shown).
Discussion
The proteins of pancreatic secretion in a variety of animal species have been the subject of so many studies, that recent reports suggesting the presence of a new protein entity in pancreatic juice, abundant (up to 14% of total exported protein) and related to a polypeptide found in pancreatic stones, were understandably received with some reservation. Scheele (40) , however, already observed by double-dimension gel analysis of human pancreatic proteins the presence of several spots in the 16-19-kD region, with acidic isoelectric points. These spots were eventually attributed to the secretory form of PSP-S. Also, Gross et al. (7) reported the presence of a 1 5-kD protein forming fibrillar aggregates in the juice of PTP. Sequence comparison between PTP and PSP-S revealed that PTP and PSP-S 1, the carboxy-terminal part of PSP-S generated by trypsin-like cleavage of the Arg-Ile bond in positions 1 These data indicate that the threonine in position 5 seems the most probable 0-glycosylation site of the molecule. The carboxy-terminal amino acid predicted by the mRNA sequence is that of PSP-S 1. Hence, no carboxy-terminal proteolysis occurs in the posttranslational processing of pre-PSP-S.
A computer search for overall sequence homology confirmed that PSP-S was distinct from the other pancreatic proteins described to date. In particular, no structural evidence could be found supporting the results of Amouric et al. (42) that PSP-S 1, called "protein X" by these authors, was in fact a degradation product generated by rapid activation of trypsinogen. ease inhibitors (4). Hence, PSP-S transformation takes A search conducted by Petersen (43) amounts of the corresponding mRNAs (5 1), we measured by NA concentrations were measured by dot-blot hybridization of quantitative filter hybridization the amount of PSP-S mRNA al amounts of RNA from control (Cont.) or CCP tissues (CCP) to in total pancreatic RNA from controls and CCP patients. It labeled cDNA probes. They were expressed as arbitrary OD492 was found three times lower in the latter group, whereas the g RNA obtained after scanning the autoradiograms of the blots.
amounts of trypsinogen, chymotrypsinogen, and colipase dividual data controls; and u, individual data CCP patients, remRNA were not altered. Thus, a specific decrease in tissular tively; X, mean values (±SE) for each group. . in the CCP ps, the patient presenting with a mild form of the disease (see PSP-S mRNA concentration is associated with CCP. A coments). The significance of the difference in PSP-S mRNA concenparable decrease in the rate of PSP-S biosynthesis is therefore ion between controls and CCP patients was estimated by Wil- expected, which could account for the decreased PSP-S levels an test (52) .
observed in CCP juice.
Whether decreased PSP-S gene expression is primary or secondary to the disease is not established. There are, however, indications that the decrease is not a mere consequence of pancreatitis. For instance, PSP-S mRNA levels ofpatients with obstructive pancreatitis, where the lesions are very similar to those of CCP, were not different from levels of patients without pancreatic disease (Fig. 6) . Moreover, in a patient with typical but very mild lesions of CCP and no pancreatic insufficiency, PSP-S mRNA level was still lower than in controls. If this was confirmed, it would suggest that altered PSP-S gene expression confers predisposition to CCP.
